Cornerstone Pharmaceuticals
A Singular Focus on Cancer Metabolism
About
Overview
Leadership
Non-Executive Directors
Advisory Board Members
Cancer Metabolism
Overview
Our Approach
Platforms & Pipelines
Pipeline
AEMD/CPI-613
Emulsiphan/EmPAC
Clinical Trials
News & Media
Press Releases
News Coverage
Press Kit
Press Contacts
Scientific Papers and Abstracts
Careers
Contact
Home
>
News & Media
>
News Coverage
News Coverage
September 2011
BioCentury: Powering down cancer
April 2011
BioPharm Insight: Cornerstone Pharmaceuticals to seek CRO bids for Phase II oncology trial; considering capital raise by end of year
March 2011
SciBX: Targeting T cell metabolism
December 2010
The New York Times: Fuel lines of tumors are new target
September 2010
Cornerstone featured in Start-Up Magazine profile
September 2010
Start Up magazine: Biotechs target cancer metabolism
August 2010
Drug Discovery News special report: Trends in cancer research
June 2010
NJBiz: Life Sciences Funding Clinical trials, new hires with tax credit
May 2010
Drug Discovery News: Cancer research turns a corner
September 2009
SBU Couple Develop Cancer Treatment Together
Next »